Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlternative Liq Regulatory News (ALF)

Share Price Information for Alternative Liq (ALF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.0275
Bid: 0.015
Ask: 0.04
Change: 0.00 (0.00%)
Spread: 0.025 (166.667%)
Open: 0.0275
High: 0.0275
Low: 0.0275
Prev. Close: 0.0275
ALF Live PriceLast checked at -
Alternative Liquidity Fund is an Investment Trust

To generate total returns for investors through the management and realisation of its portfolio by investing globally in a portfolio of illiquid assets, which is expected to comprise predominantly of investments in funds.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of Meeting

25 Feb 2019 09:34

RNS Number : 0001R
Alternative Liquidity Fund Limited
25 February 2019
 

ALTERNATIVE LIQUIDITY FUND LIMITED

Registered in Guernsey - Number 60552

LEI NUMBER 213800R5CHD76J3LU713

 

Registered Office:

Sarnia House, Le Truchot,

St Peter Port, Guernsey, GY1 1GR

 

25 FEBRUARY 2019

 

EXTRAORDINARY GENERAL MEETING VOTING RESULTS

Alternative Liquidity Fund Limited ("ALF" or the "Company") is pleased to announce that at the Extraordinary General Meeting ("EGM") held at 9:00 a.m. today, 25 February 2019, each of the Resolutions was duly passed without amendment.

 

In accordance with LR 9.6.18, details of the results of those resolutions proposed at the EGM follow:

 

Resolution

For (including discretionary)

Against

Withheld*

1 - Ordinary

82,627,062

7,042,837

50,000

2 - Special

82,627,062

7,042,837

50,000

3 - Extraordinary

82,627,062

7,042,837

50,000

4 - Ordinary

43,350,889

7,042,837

39,326,173

5 - Ordinary

53,820,039

7,042,837

28,857,023

6 - Ordinary

78,682,254

7,042,837

3,994,808

7 - Special

82,627,062

7,042,837

50,000

 

 

 

 

*A vote withheld is not a vote in law and is therefore not counted towards the proportion of votes "for" or "against" the Resolution.

 

The full wording of these resolutions can be found below:-

 

Resolution 1 - Ordinary Resolution

 

THAT subject to the passing of Resolution 2 the proposed investment objective and policy set out in the circular to the shareholders of the Company dated 6 February 2019, a copy of which has been produced to the meeting and signed by the Chairman for the purposes of identification (the "Circular"), be and is hereby adopted as the investment objective and policy of the Company to the exclusion of all previous investment policies of the Company.

 

Resolution 2 - Special Resolution

 

THAT subject to the passing of Resolution 1 the draft articles produced to the meeting and, for the purposes of identification, initialled by the Chairman of the meeting (the "New Articles") be adopted as the articles of incorporation of the Company in substitution for, and to the entire exclusion of, the existing articles of incorporation of the Company, whereby the existing ordinary shares of US$0.01 each issued in the capital of the Company be redesignated as "Realisation Shares" having the rights thereto as prescribed in the New Articles.

 

Resolution 3 - Extraordinary Resolution

 

THAT, subject to the passing of Resolution 1 and Resolution 2, the Directors of the Company be and they are hereby generally empowered, in respect of the Initial Placing and Offer (as such terms are defined in the Circular) to allot and issue, to grant rights to subscribe for, or to convert and make offers or agreements to allot equity shares (as detailed in Article 6.1 of the New Articles) for cash as if the pre-emption rights contained in the New Articles in respect of such equity securities did not apply to any such allotment, provided that this power shall:

a) expire on the date falling 12 months from the date of the passing of this resolution, save that the Company may, before such expiry, make an offer or agreement which would or might require equity securities to be allotted after such expiry and the Directors may allot equity securities in pursuance of any such offer or agreement as if the power conferred hereby had not expired; and

b) shall be limited to the allotment of equity securities in respect of the Initial Placing Offer (as such terms are defined in the Circular) up to an aggregate nominal value of US$1,000,000 being approximately 68 per cent. of the nominal value of the issued share capital of the Company, as at 4 February 2019.

 

Resolution 4 - Ordinary Resolution

 

THAT, subject to the passing of all of the other Resolution 1 and Resolution 2 the Sunrise Partners Related Party Transaction (as defined in the Circular), being a related party transaction for the purpose of the Listing Rules of the UK Listing Authority be and is hereby approved.

 

Resolution 5 - Ordinary Resolution

 

THAT, subject to the passing of all of the other Resolution 1 and Resolution 2 the LIM Related Party Transaction (as defined in the Circular), being a related party transaction for the purpose of the Listing Rules of the UK Listing Authority be and is hereby approved.

 

Resolution 6 - Ordinary Resolution

 

THAT, subject to the passing of all of the other Resolution 1 and Resolution 2 the entering into of the Supplemental Agreement to the Investment Management Agreement (as defined in the Circular) by the Company, being a related party transaction for the purpose of the Listing Rules of the UK Listing Authority be and is hereby approved.

 

Resolution 7 - Special Resolution

 

THAT, subject to the passing of Resolution 1 and Resolution 2, the Company be generally and unconditionally authorised, in accordance with the Companies (Guernsey) Law, 2008 (as amended) (the "Law") to make market acquisitions (as defined in that Law) of Ordinary Shares of US$0.01 ("Ordinary Shares"), either for retention as treasury shares for future resale or transfer or cancelletion, provided that:

 

a) the maximum number of Ordinary Shares hereby authorised to be purchased shall be

14.99 per cent. of the issued Ordinary Shares on the date of Admission (as defined in the

Circular);

 

b) the minimum price which may be paid for an Ordinary Share shall beUS$0.01 per share;

 

c) the maximum price (exclusive of expenses) which may be paid for an Ordinary Share shall

be an amount equal to the higher of (i) 105 per cent. of the average of the middle market

quotations (as derived from the Daily Official List) of the Ordinary Shares for the five

business days immediately preceding the date of purchase and (ii) the higher of the latest

independent trade and the highest current independent bid on the trading venue on which

the purchase is carried out: and

 

d) unless previously varied, revoked or renewed, the authority hereby conferred shall expire

15months from the date of this resolution or, if earlier, at the conclusion of the next annual

general meeting of the Company, save that the company may, prior to such expiry, enter

into a contract to purchase Ordinary Shares under such authority and may make a purchase

of Ordinary Shares pursuant to any such contract.

 

ENDS

 

All Enquiries

 

Tim Gardner, Warana Capital, LLP

Tel. +44 20 3551 2917

Email. tg@waranacap.com

Website: https://waranacap.com/

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ROMKELBLKLFXBBL
Date   Source Headline
20th Mar 20241:55 pmRNSHalf-year Report
27th Feb 20242:00 pmRNSNet Asset Value and Factsheet
6th Dec 20232:03 pmRNSResult of AGM
27th Nov 20232:00 pmRNSNet Asset Value and Factsheet
21st Nov 20231:45 pmRNSNotice of AGM
26th Oct 20238:36 amRNSAnnual Financial Report
29th Sep 20237:00 amRNSTotal Voting Rights
8th Sep 20237:00 amRNSCancellation of Shares
30th Aug 20232:00 pmRNSPortfolio Update
29th Aug 202310:30 amRNSNet Asset Value and Factsheet
19th Jun 202311:30 amRNSFinal Net Asset Value & Factsheet
23rd Mar 20237:00 amRNSHalf-year Report
20th Mar 20239:05 amRNSSecond Price Monitoring Extn
20th Mar 20239:00 amRNSPrice Monitoring Extension
23rd Feb 202312:00 pmRNSNet Asset Value and Factsheet
14th Feb 20234:40 pmRNSSecond Price Monitoring Extn
14th Feb 20234:35 pmRNSPrice Monitoring Extension
14th Feb 20232:05 pmRNSSecond Price Monitoring Extn
14th Feb 20232:00 pmRNSPrice Monitoring Extension
14th Feb 202311:05 amRNSSecond Price Monitoring Extn
14th Feb 202311:00 amRNSPrice Monitoring Extension
13th Feb 20239:00 amRNSChange of Registered Office
25th Jan 20234:40 pmRNSSecond Price Monitoring Extn
25th Jan 20234:35 pmRNSPrice Monitoring Extension
25th Jan 20232:05 pmRNSSecond Price Monitoring Extn
25th Jan 20232:00 pmRNSPrice Monitoring Extension
25th Jan 202311:05 amRNSSecond Price Monitoring Extn
25th Jan 202311:00 amRNSPrice Monitoring Extension
25th Jan 20239:05 amRNSSecond Price Monitoring Extn
25th Jan 20239:00 amRNSPrice Monitoring Extension
23rd Jan 20234:40 pmRNSSecond Price Monitoring Extn
23rd Jan 20234:35 pmRNSPrice Monitoring Extension
23rd Jan 20232:05 pmRNSSecond Price Monitoring Extn
23rd Jan 20232:00 pmRNSPrice Monitoring Extension
6th Jan 20239:05 amRNSSecond Price Monitoring Extn
6th Jan 20239:00 amRNSPrice Monitoring Extension
5th Jan 20235:00 pmRNSReturn of Capital
21st Dec 20222:05 pmRNSSecond Price Monitoring Extn
21st Dec 20222:00 pmRNSPrice Monitoring Extension
15th Dec 20224:40 pmRNSSecond Price Monitoring Extn
15th Dec 20224:35 pmRNSPrice Monitoring Extension
15th Dec 20222:05 pmRNSSecond Price Monitoring Extn
15th Dec 20222:00 pmRNSPrice Monitoring Extension
7th Dec 20221:25 pmRNSResult of AGM
5th Dec 202212:00 pmRNSNet Asset Value and Factsheet
17th Nov 20222:05 pmRNSSecond Price Monitoring Extn
17th Nov 20222:00 pmRNSPrice Monitoring Extension
11th Nov 202211:05 amRNSSecond Price Monitoring Extn
11th Nov 202211:00 amRNSPrice Monitoring Extension
1st Nov 20224:36 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.